666
F. Nikpour et al.
(CDCl3): ꢃ ¼ 197.4, 160.4, 138.8, 134.6, 133.7, 129.9, 129.2,
128.8, 127.4, þ126.4, 76.7, 75.0, 21.2 ppm; MS (EI): m=z
(%) ¼ 281 (M ꢃ, 4), 253 (4), 237 (13), 222 (15), 105 (100),
cis-5-(4-Bromobenzoyl)-4-phenyloxozolidin-2-one (cis-2f,
C16H12BrNO3)
IR (liquid film): ꢂꢀ¼ 3205 (NH), 1742 (CO-carbamate),
1
1684 (CO-ketone) cmꢀ1; H NMR (CDCl3): ꢃ ¼ 7.41, 7.36
91 (67), 77 (31).
3
(2d, JHH ¼ 8.5 Hz, 4H–Ar), 7.17–7.11 (m, 5H–Ar), 6.31 (d,
3JHH ¼ 3.0 Hz, C5–H), 5.55 (bs, C4–H), 3.84 (bs, NH) ppm;
13C NMR (CDCl3): ꢃ ¼ 196.0, 164.2, 132.3, 131.1, 129.9,
129.1, 128.7, 128.1, 127.6, 126.9, 77.0, 74.5ppm; MS (EI):
trans-5-Benzoyl-4-(4-methylphenyl)oxozolidin-2-one (trans-
2b, C17H15NO3)
IR (liquid film): ꢂꢀ¼ 3460 (NH), 1719 (CO-carbamate), 1686
þ
þ
1
3
m=z (%) ¼ 347 ([M ꢃþ 2], 2), 345 (M ꢃ, 2), 304 (8), 302 (7),
(CO-ketone) cmꢀ1; H NMR (CDCl3): ꢃ ¼ 7.90 (dd, JHH
¼
¼
4
3
4
185 (100), 183 (98), 104 (53), 77 (45).
8.2 Hz, JHH ¼ 1.5 Hz, 2H–Ar), 7.53 (dd, JHH ¼ 7.7, JHH
3
1.5 Hz, 1H–Ar), 7.33 (d, JHH ¼ 8.2 Hz, 2H–Ar), 7.28 (d,
3JHH ¼ 7.7 Hz, 2H–Ar), 7.16 (d, JHH ¼ 8.0 Hz, 2H–Ar), 6.17
3
Acknowledgements
(d, 3JHH ¼ 2.5 Hz, C5–H), 5.33 (m, C4–H), 3.89 (bs, NH), 2.33
(s, CH3) ppm; 13C NMR (CDCl3): ꢃ ¼ 198.1, 159.4, 138.6,
134.3, 133.4, 129.2, 129.0, 128.6, 127.0, 126.4, 75.4, 75.3,
We are grateful to the University of Kurdistan Research
Council for the partial support of this work.
þ
21.2ppm; MS (EI): m=z (%) ¼ 281 (M ꢃ, 5), 253 (6), 237
(10), 222 (9), 105 (100), 91 (77), 77 (23).
References
cis-5-(4-Methylbenzoyl)-4-(4-methylphenyl)oxozolidin-2-
one (cis-2c, C18H17NO3)
1. a) Friestad GK, Qin J (2000) J Am Chem Soc 122:8329; b)
Bull SD, Davies SG, Nicholson RL, Sanganee HJ, Smith
AD (2000) Tetrahedron: Asymmetry 11:3475; c) Bravo P,
Fustero S, Guidetti M, Volonterio A, Zanda M (1999) J Org
Chem 64:8731; d) Bull SD, Davies SG, Jones S, Sanganee
HJ (1999) J Chem Soc Perkin Trans 1:387; e) Davies SG,
Sanganee HJ, Szolcsanyi P (1999) Tetrahedron 55:3337; f)
Reddy GV, Rao GV, Iyengar DS (1999) Chem Commun:
317; g) Ager DJ, Prakash I, Schaad DR (1996) Chem Rev
96:835
2. a) Takhi M, Murugan C, Munikumar M, Bhaskarreddy KM,
Singh G, Sreenivas K, Sitaramkumar M, Selvakumar N, Das
J, Trehan S, Iqbal J (2006) Bioorg Med Chem Lett 16:2391;
b) Wang G, Ella-Menye JR, Sharma V (2006) Bioorg Med
Chem Lett 16:2177; c) Selvakumar N, Kumar GS, Azhagan
AM, Rajulu GG, Sharma S, Kumar MS, Das J, Iqbal J,
Trehan S (2007) Eur J Med Chem 42:538; d) Jandu KS,
Barrett V, Brockwell M, Cambridge D, Farrant DR, Foster
C, Giles H, Glen RC, Hill AP, Hobbs H, Honey A, Martin
GR, Salmon J, Smith D, Woollard P, Selwood DL (2001) J
Med Chem 44:681
Mp 93–95ꢁC from n-hexane. IR (KBr): ꢂꢀ¼ 3375 (NH), 1736
(CO-carbamate), 1679 (CO-ketone) cmꢀ1; 1H NMR (CDCl3):
3
3
ꢃ ¼ 8.00 (d, JHH ¼ 7.8 Hz, 2H–Ar), 7.36 (d, JHH ¼ 7.8 Hz,
3
3
2H–Ar), 7.25 (d, JHH ¼ 5.5 Hz, 2H–Ar), 7.09 (d, JHH
¼
5.5 Hz, 2H–Ar), 6.14 (d, JHH ¼ 3.0 Hz, C5–H), 5.72 (dd,
3
3JNH ¼ 7.2 Hz, JHH ¼ 3.0 Hz, C4–H), 3.65 (d, JNH ¼ 7.2 Hz,
NH), 2.47, 2.16 (2s, 2CH3) ppm; 13C NMR (CDCl3):
ꢃ ¼ 197.2, 166.2, 145.7, 133.7, 131.3, 129.9, 129.1, 128.6,
128.0, 127.5,þ77.2, 75.0, 21.9, 19.3ppm; MS (EI): m=z
(%) ¼ 295 (M ꢃ, 3), 267 (1), 236 (5), 150 (21), 119 (100),
3
3
105 (14), 91 (77), 77 (23).
cis-5-(4-Methoxybenzoyl)-4-phenyloxozolidin-2-one (cis-2d,
C17H15NO4)
IR (liquid film): ꢂꢀ¼ 3455 (NH), 1720 (CO-carbamate), 1673
1
3
(CO-ketone) cmꢀ1; H NMR (CDCl3): ꢃ ¼ 8.06 (d, JHH
¼
3
7.0 Hz, 2H–Ar), 7.30 (d, JHH ¼ 8.2 Hz, 2H–Ar), 7.26 (d,
3JHH ¼ 7.5 Hz, 2H–Ar), 7.11 (dd, JHH ¼ 7.2, JHH
¼
3
4
3
1.5 Hz, 1H–Ar), 7.08 (d, JHH ¼ 7.0 Hz, 2H–Ar), 6.28 (d,
3JHH ¼ 2.5 Hz, C5–H), 5.56 (bs, C4–H), 3.93 (s, OCH3),
3.75 (bs, NH) ppm; 13C NMR (CDCl3): ꢃ ¼ 195.3, 164.7,
160.5, 133.8, 129.9, 129.3, 128.9, 128.1, 127.5, 114.5, 76.8,
3. a) Liu JM, Peng XG, Liu JH, Zheng SZ, Sun W, Xia CG
(2007) Tetrahedron Lett 48:929; b) Hamdach A,
´
´
´
Zaragoza RJ, Zaballos-Garcıa E, Sepulveda-Arques J
(2007) J Mol Struc: THEOCHEM 806:141; c) Boyd E,
Chavda S, Coulbeck E, Coumbarides GS, Dingjan M,
Eames J, Flinn A, Krishnamurthy AK, Namutebi M,
Northen J, Yohannes Y (2006) Tetrahedron: Asymmetry
17:3406; d) Hein JE, Geary LM, Jaworski AA, Hultin PG
(2005) J Org Chem 70:9940; e) Ciclosi M, Fava C,
þ
74.6, 55.7 ppm; MS (EI): m=z (%) ¼ 297 (M ꢃ, 1), 254 (27),
253 (7), 135 (100), 107 (17), 105 (18), 77 (44).
cis-5-(4-Methoxybenzoyl)-4-(4-methoxyphenyl)oxozolidin-2-
one (cis-2e, C18H17NO5)
IR (liquid film): ꢂꢀ¼ 3450 (NH), 1719 (CO-carbamate), 1676
´
Galeazzi R, Orena M, Gonzalez-Rosende ME, Sepulveda-
1
3
(CO-ketone) cmꢀ1; H NMR (CDCl3): ꢃ ¼ 8.07 (d, JHH
¼
¼
Arques J (2004) Tetrahedron: Asymmetry 15:1937; f)
Park CS, Kim MS, Sim TB, Pyun DK, Lee CH, Choi D,
Lee WK (2003) J Org Chem 68:43; g) Coelho F, Rossi RC
(2002) Tetrahedron Lett 43:2797; h) Feroci M, Gennaro
A, Inesi A, Orsini M, Palomb L (2002) Tetrahedron Lett
43:5863
3
8.5 Hz, 2H–Ar), 7.05–7.00 (m, 4H–Ar), 6.77 (d, JHH
3
8.5 Hz, 2H–Ar), 6.23 (d, JHH ¼ 3.0 Hz, C5–H), 5.54 (dd,
3
3JNH ¼ 6.5, JHH ¼ 3.0 Hz, C4–H), 3.94 and 3.77 (2s,
3
2CH3O), 3.88 (d, JNH ¼ 6.5 Hz, NH) ppm; 13C NMR
(CDCl3): ꢃ ¼ 196.1, 164.7, 160.5, 131.3, 128.9, 126.5, 125.1,
118.7, 114.5, 113.5, 77.2, 74.6, 55.6, 55.2ppm; MS (EI): m=z
´
4. Hamdach A, El-Hadrami EM, Gil S, Zaragoza RJ,
Zaballos-Garcı E, Sepulveda-Arques J (2006) Tetrahedron
þ
(%) ¼ 284 (M ꢃ-HNCO, 5), 283 (4), 177 (13), 135 (100), 107
´
´
(47), 92 (41), 77 (35).
62:6392